The Lancet Infectious Diseases in conversation with
Saleha Hassan, Senior Editor at The Lancet Infectious Diseases, in conversation with the journal’s authors, explores their latest research and its impact on people’s health, healthcare, and health policy.
A monthly audio companion to the journal, this podcast covers a broad range of topics, from polio eradication in Africa to COVID-19 vaccines in Hong Kong, the treatment of early syphilis in adults to Mpox in the UK, and more.
Episodes
81 episodes
Catherine Liu and Joshua Hill on prevention and management of infections in people who are immunocompromised
Drs Catherine Liu and Joshua Hill of the Fred Hutchinson Cancer Center discuss their new Series of papers on the prevention and management of infections in people who are immunocompromised, with a focus on prevention of infections and diagnosti...
•
18:27
Lilian Tina Minja and Norbert Heinrich on TB drug development
Lilian Tina Minja and Norbert Heinrich discuss the SUDUCO and DECODE trials in The Lancet Infectious Diseases on two new promising TB drugs, sutezolid and delpazolid, respectively. They also discuss the wider implications of the findin...
•
29:53
Leonardo Basso and Juan Pablo Torres on the NIRSE-CL study of nirsevimab in Chile
Leonardo Basso and Juan Pablo Torres discuss their study in The Lancet Infectious Diseases on the effectiveness and impact of the first season of Chile's national immunisation programme with nirsevimab. They discuss the evidence that l...
•
15:27
Jan Felix Drexler and Fernando Bozza on Oropouche virus
Jan Felix Drexler and Fernando Bozza discuss their recent study published in the journal— “The spatio-temporal ecology of Oropouche virus: a laboratory-based modelling study across Latin America” and its wider implications for Oropouche virus a...
•
35:17
Prasad Kulkarni on dengue monoclonal antibodies
Prasad Kulkarni discusses a new Phase I trial in The Lancet Infectious Diseases on a dengue monoclonal antibody also known as VIS513 in healthy adults. In addition, he highlights the wider implications of this for dengue control and dr...
•
18:53
Oriol Mitjà on treatment of early syphilis in adults
Oriol Mitjà discusses a new trial in The Lancet Infectious Diseases on the use of oral linezolid compared with benzathine penicillin G for the treatment of early syphilis in adults. He also highlights what the trial means for treatment...
•
15:25
Sofia Viegas and Stefan Niemann on emerging bedaquiline resistance in Mozambique
Sofia Viegas and Stefan Niemann discuss a new article in The Lancet Infectious Diseases about emerging bedaquiline resistance in Mozambique and its implications for drug resistant tuberculosis and the fight to end tuberculosis....
•
24:35
Luciano Moreira and Henrik Salje on Wolbachia control of mosquito-borne infections
Luciano Moreira and Henrik Salje discuss a new article in The Lancet Infectious Diseases describing the use of the Wolbachia bacteria to control the spread of mosquito-borne dengue and chikungunya in Rio de Janeiro, Brazil.
•
17:01
Richard Maude on malaria chemoprophylaxis in Cambodia
Richard Maude discusses a new article in The Lancet Infectious Diseases that assesses the efficacy of malaria chemoprophylaxis among forest goers in Cambodia.Read the full article:
•
12:44
Ben Cowling on COVID-19 vaccines in Hong Kong
Ben Cowling discusses a new article in The Lancet Infectious Diseases describing the protection that vaccines are providing against COVID-19 in Hong Kong.Read the full article:
•
20:58
Hugh Adler on monkeypox in the UK
Hugh Adler discusses a new article in The Lancet Infectious Diseases describing the management and the clinical features for seven patients with monkeypox hospitalised in the UK between 2018 and 2021.Read the full article:<...
•
18:17
Beate Kampmann, Karen Keddy, and Peter Ghazal on applying big data to childhood infectious diseases in LMICs
Prof Beate Kampmann, Dr Karen Keddy, and Prof Peter Ghazal discuss a new cross-journal Series in The Lancet Infectious Diseases and EBioMedicine addressing the potential for and challenge of applying big data to childhood infe...
•
22:16
Laura Cooper and Sam Okiror on polio eradication in Africa
A new article highlights how changing immunity profiles motivate the need for better responses to outbreaks of polio in Africa.Read the full article:https://www.thelancet.com/journals/laninf/article/PIIS1473-3099(21)00453-9/fulltext...
•
21:34
Paul Chapman on a hookworm vaccine
Paul Chapman and colleagues presents the results of an innovative trial assessing the safety of vaccinating healthy volunteers with attenuated Necator americanus hookworm larvae. Read the full article:https://www.thela...
•
20:57
Josep Llibre on preventing SARS-CoV-2 transmission at concerts
Josep Llibre discusses a trial on the impact of same-day testing for SARS-CoV-2 infection before a concert on new COVID-19 cases in Barcelona, Spain.Read the full article:https://www.thelancet.com/journals/laninf/article/PIIS1473-30...
•
8:10
Yap Boum on COVID-19 testing in low resource settings
Yap Boum (MSF) discusses his study done in Cameroon, which developed a promising testing strategy for COVID-19 to optimise the available resources.Read the full article:https://www.thelancet.com/journals/laninf/article/PIIS1473-3099...
•
11:21
Antimalarial resistance in southeast Asia
Two studies in The Lancet Infectious Diseases describe how the spread of resistance to both dihydroartemisinin and piperaquine is compromising malaria therapy in South-East Asia
•
13:06
Trial in phage therapy for burn infections
A trial investigates the use of a cocktail of phages for the therapy of infections in patients with burns.
•
29:29
Pandemic influenza: 100 years
Editor of The Lancet Infectious Diseases, John McConnell, discusses the 1918 influenza pandemic and the lessons that can be learnt from it with John Oxford and Jeffery Taubenberger.
•
18:34
Bedaquiline and delamanid combination for drug-resistant TB: The Lancet Infectious Diseases: February 13, 2018
Amir Shroufi discusses the early results assessing the safety and efficacy of the combination of bedaquiline and delamanid against drug-resistant tuberculosis.
•
14:11
MERS and transchromosomic cows: The Lancet Infectious Diseases: January 10, 2018
John Beigel, an author, and Eddie Sullivan discuss a phase 1 study assessing the safety and tolerability of human antibodies manufactured in transchromosomic cows for treatment of MERS.
•
12:00
PrEP in the UK: The Lancet Infectious Diseases: October 17, 2017
Valentina Cambiano discusses the cost-effectiveness of pre-exposure prophylaxis medication in the UK.
•
6:33
Polio in Afghanistan: The Lancet Infectious Diseases: August 14, 2017
Christina Wayman talks to Gillian SteelFisher about polio vaccination in Afghanistan.
•
16:23